Article
T cell protein tyrosine phosphatase protects intestinal barrier function by restricting epithelial tight junction remodeling.
The Journal of clinical investigation - 1 Sept 2021
Marchelletta Ronald R, Krishnan Moorthy, Spalinger Marianne R, Placone Taylaur W, Alvarez Rocio, Sayoc-Becerra Anica, Canale Vinicius, Shawki Ali, Park Young Su, Bernts Lucas Hp, Myers Stephen, Tremblay Michel L, Barrett Kim E, Krystofiak Evan, Kachar Bechara, McGovern Dermot Pb, Weber Christopher R, Hanson Elaine M, Eckmann Lars, McCole Declan F
Abstract excerpt
Genome-wide association studies revealed that loss-of-function mutations in protein tyrosine phosphatase non-receptor type 2 (PTPN2) increase the risk of developing chronic immune diseases, such as inflammatory bowel disease (IBD) and celiac disease. These conditions are associated with increased intestinal permeability as an early etiological event. The aim of this study was to examine the consequences of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
